Screener
Rapport Therapeutics, Inc. RAPP Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Short-term investments | 372,465 | 437,894 |
| Restricted cash | 105 | 105 |
| Prepaid expenses and other current assets | 10,381 | 7,917 |
| Total current assets | 446,856 | 498,561 |
| Property and equipment, net | 2,337 | 2,976 |
| Operating lease right of use asset, net | 8,732 | 9,909 |
| Other assets | 1,057 | 985 |
| Total assets | $458,982 | $512,431 |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s total current assets?
- Rapport Therapeutics, Inc. (RAPP) reported total current assets of $446.86M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s total current assets changed year-over-year?
- Rapport Therapeutics, Inc.'s total current assets increased by 65.4% year-over-year, from $270.24M to $446.86M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s total current assets?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total current assets has grown at a 81.8% compound annual growth rate (CAGR), from $150.87M to $498.56M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Rapport Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude